Roles of the carboxy-terminal half of Pseudomonas aeruginosa major outer membrane protein OprF in cell shape, growth in low-osmolarity medium, and peptidoglycan association

Journal of Bacteriology

Volumn 180, Issue 14, 1998, Pages 3556-3562

  Rawling, Eileen G ^a   Brinkman, Fiona S L ^a   Hancock, Robert E W ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

OUTER MEMBRANE PROTEIN; PEPTIDOGLYCAN; PROTEIN OPRF; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; CARBOXY TERMINAL SEQUENCE; CELL SHAPE; CONTROLLED STUDY; MOUSE; NONHUMAN; OPPORTUNISTIC INFECTION; OSMOLARITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PSEUDOMONAS AERUGINOSA;

ANIMALIA; BACTERIA (MICROORGANISMS); NEGIBACTERIA; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 0032447956     PISSN: 00219193     EISSN: None     Source Type: Journal    
DOI: 10.1128/jb.180.14.3556-3562.1998     Document Type: Article

References (49)

1. Battershill, J., D. P. Speert, and R. E. W. Hancock. 1987. Use of monoclonal antibodies against protein F of Pseudomonas aeruginosa as opsonins for phagocytosis by macrophages. Infect. Immun. 55:2531-2533.
2. Birnboim, H. C., and J. Doly. 1979. A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res. 7:1513-1523.
3. Blackwood, L. L., and J. E. Pennington. 1981. Influence of mucoid coating on clearance of Pseudomonas aeruginosa. Infect. Immun. 32:443-448.
4. Bremer, E., S. T. Cole, I. Hindennach, U. Henning, E. Beck, C. Kurz, and H. Schaller. 1982. Export of a protein into the outer membrane of Escherichia coli K12: stable incorporation of the OmpA protein requires less than 193 amino-terminal amino-acids residues. Eur. J. Biochem. 122:223-231.
5. Bryan, L. E. 1979. Resistance to antimicrobial agents: the general nature of the problem and the basis of resistance, p. 219-270. In R. Doggett (ed.), Pseudomonas aeruginosa: clinical manifestations of infection and current therapy. Academic Press, New York, N.Y.
6. Chamberland, S., F. Malouin, H. R. Rabin, T. Schollaardt, T. R. Parr, Jr., and L. E. Bryan. 1990. Persistence of Pseudomonas aeruginosa during ciprofloxacin therapy of a cystic fibrosis patient: transient resistance to quinolones and protein F-deficiency. J. Antimicrob. Chem. 25:995-1010.
7. Day, S. E. J., K. K. Vasil, R. J. Russel, and J. P. Arbuthnott. 1980. A simple method for the study in vivo of bacteria growth and accompanying host response. J. Infect. Dis. 2:39-51.
8. de Cock, H., M. Struyvé, M. Kleerebesem, T. van der Krift, and J. Tommassen. 1997. Role of the carboxy-terminal phenylalanine in the biogenesis of outer membrane protein PhoE of Escherichia coli K-12. J. Mol. Biol. 269: 473-478.
9. De Mot, R., and J. Vanderleyden. 1994. MicroCorrespondence. Mol. Microbiol. 13:379-380.
10. Farinha, M. A., and A. M. Kropinski. 1990. High efficiency electroporation of Pseudomonas aeruginosa using frozen cell suspensions. FEMS Microbiol. Lett. 70:221-226.
11. Fellay, R., J. Frey, and H. Krisch. 1987. Interposon mutagenesis of soil and water bacteria: a family of DNA fragments designed for in vitro insertional mutagenesis of Gram-negative bacteria. Gene 52:147-154.
12. Finnen, R. L., N. L. Martin, R. J. Siehnel, W. A. Woodruff, M. Rosok, and R. E. W. Hancock. 1992. Analysis of the major outer membrane protein OprF from Pseudomonas aeruginosa using truncated derivatives and monoclonal antibodies. J. Bacteriol. 174:4977-4985.
13. Gilleland, H. E., Jr., M. G. Parker, J. M. Matthews, and R. D. Berg. 1984. Use of a purified outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine in mice. Infect. Immun. 44:49-54.
14. Goldberg, J. B., and D. E. Ohman. 1984. Cloning and expression in Pseudomonas aeruginosa of a gene involved in the production of alginate. J. Bacteriol. 158:1115-1121.
15. Gotoh, N., H. Wakebe, and T. Nishino. 1989. Ultrastructural aspects of fragility of Pseudomonas aeruginosa outer membrane devoid of protein F. FEMS Microbiol. Lett. 59:51-54.
16. Gotoh, N., H. Wakebe, and E. Yoshihara. 1989. Role of protein F in maintaining structural integrity of the Pseudomonas aeruginosa outer membrane. J. Bacteriol. 171:983-990.
17. Hancock, R. E. W., and A. M. Carey. 1979. Outer membrane of Pseudomonas aeruginosa: heat- and 2-mercaptoethanol-modifiable proteins. J. Bacteriol. 140:902-910.
18. Hancock, R. E. W., R. T. Irwin, J. W. Costerton, and A. M. Carey. 1981. The outer membrane of Pseudomonas aeruginosa: peptidoglycan associated proteins. J. Bacteriol. 145:628-631.
19. Hancock, R. E. W., L. M. Mutharia, and E. C. A. Mouat. 1985. Immunotherapeutic potential of monoclonal antibodies against Pseudomonas aeruginosa protein F. Eur. J. Clin. Microbiol. 4:224-227.
20. Hancock, R. E. W., R. Siehnel, and N. Martin. 1990. Outer membrane proteins of Pseudomonas. Mol. Microbiol. 4:1069-1075.
21. Jeanteur, D., J. H. Lakey, and F. Pattus. 1991. The bacterial porin superfamily: sequence alignment and structure prediction. Mol. Microbiol. 5: 2153-2164.
22. Jeanteur, D., J. H. Lakey, and F. Pattus. 1994. The porin superfamily: diversity and common features, p. 363-380. In J.-M. Ghuysen and R. Hakenbeck (ed.), Bacterial cell wall. Elsevier, Amsterdam, The Netherlands.
23. Martin, N. L., E. G. Rawling, R. S. Y. Wong, M. Rosok, and R. E. W. Hancock. 1993. Conservation of surface epitopes in Pseudomonas aeruginosa outer membrane porin protein OprF. FEMS Microbiol. Lett. 113:261-266.
24. Mutharia, L. M., and R. E. W. Hancock. 1983. Surface localization of Pseudomonas aeruginosa outer membrane porin protein using monoclonal antibodies. Infect. Immun. 42:1027-1033.
25. Mutharia, L. M., and R. E. W. Hancock. 1985. Characterization of two surface-localized antigenic sites on porin protein F of Pseudomonas aeruginosa. Can. J. Microbiol. 31:381-390.
26. Nicas, T. I., and R. E. W. Hancock. 1983. Pseudomonas aeruginosa outer membrane permeability: isolation of a porin F-deficient mutant. J. Bacteriol. 153:281-285.
27. Nikaido, H. 1994. Prevention of drug access to bacterial targets: permeability barriers and active efflux. Science 264:382-387.
28. Nikaido, H., and D. G. Thanassi. 1993. Penetration of lipophilic agents with multiple protonation sites into bacterial cells: tetracyclines and fluoroquinolones as examples. Antimicrob. Agents Chemother. 37:1393-1399.
29. Pennington, J. E., G. E. Small, M. E. Lostrom, and G. B. Pier. 1986. Polyclonal and monoclonal antibody therapy for exponential Pseudomonas aeruginosa pneumonia. Infect. Immun. 54:239-244.
30. Peterson, G. L. 1977. A simplification of the protein assay method of Lowry et al. which is more generally acceptable. Anal. Biochem. 83:346-356.
31. Piddock, L. J. V., M. C. Hall, F. Bellido, M. Bains, and R. E. W. Hancock. 1992. A pleiotropic, posttherapy, enoxacin-resistant mutant of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 36:1057-1061.
32. Rawling, E. G., N. L. Martin, and R. E. W. Hancock. 1995. Epitope mapping of the Pseudomonas aeruginosa major outer membrane porin protein OprF. Infect. Immun. 63:38-42.
33. Ried, G., R. Koebnik, I. Hindennach, B. Mutschler, and U. Henning. 1994. Membrane topology and assembly of the outer membrane protein OmpA of Escherichia coli K12. Mol. Gen. Genet. 243:127-135.
34. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
35. Schulz, G. E. 1993. Bacterial porins: structure and function. Curr. Opin. Cell Biol. 5:701-707.
36. Schweizer, H. P. 1991. Escherichia-Pseudomonas shuttle vectors derived from pUC18/19. Gene 97:109-112.
37. Sivaraman, T., T. K. S. Kumur, G. Jayaraman, C. C. Han, and C. Yu. 1997. Characterization of a partially structured state in an all-beta-sheet protein. Biochem. J. 321:457-464.
38. Speert, D. P., M. Bond, R. C. Woodman, and J. T. Curnutte. 1994. Infection with Pseudomonas cepacia in chronic granulomatous disease: role of non-oxidative killing by neutrophils in host defense. J. Infect. Dis. 170:1524-1531.
39. Speert, D. P., and L. Thorson. 1991. Suppression by human recombinant gamma interferon of in vitro macrophage nonopsonic and opsonic phagocytosis and killing. Infect. Immun. 59:1893-1898.
40. Stieritz, D. D., and I. A. Holder. 1975. Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: description of a burned mouse model. Infect. Immun. 131:688-691.
41. Takenaka, O., A. Takenaka, and Y. Inada. 1976. Sodium trichloroacetate-induced helical conformation of poly(L-lysine). Biochim. Biophys. Acta 439: 302-309.
42. Vogel, H., and F. Jahnig. 1986. Models for the structure of outer-membrane proteins of Escherichia coli derived from Raman spectroscopy and prediction methods. J. Mol. Biol. 190:191-199.
43. Waterhous, D. V., and W. C. Johnson. 1994. The importance of environment in determining secondary structure in protein. Biochemistry 33:212-218.
44. Wong, R. Unpublished data.
45. Wong, R. S. Y., H. Jost, and R. E. W. Hancock. 1993. Linker-insertion mutagenesis of Pseudomonas aeruginosa outer membrane protein OprF. Mol. Microbiol. 10:283-292.
46. Wong, R. S. Y., R. A. Wirtz, and R. E. W. Hancock. 1995. Pseudomonas aeruginosa outer membrane protein OprF as an expression vector for foreign epitopes: the effects of positioning and length on the antigenicity of the epitope. Gene 158:55-60.
47. Woodruff, W. A., T. R. Parr, Jr., R. E. W. Hancock, L. F. Hanne, T. I. Nicas, and B. H. Iglewski. 1986. Expression in Escherichia coli and function of Pseudomonas aeruginosa outer membrane porin protein F. J. Bacteriol. 167: 473-479.
48. Woodruff, W. A., and R. E. W. Hancock. 1988. Construction and characterization of Pseudomonas aeruginosa porin protein F-deficient mutants after in vivo and in vitro mutagenesis of the cloned protein F gene in Escherichia coli. J. Bacteriol. 170:2592-2598.
49. Woodruff, W. A., and R. E. W. Hancock. 1989. Pseudomonas aeruginosa outer membrane protein F: structural role and relationship to the Escherichia coli OmpA protein. J. Bacteriol. 171:3304-3309.